Closed · CDC-RFA-CE14-1404 · CFDA 93.136 · Discretionary
Prescription Drug Overdose: Boost for State Prevention
Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- June 4, 2014
- Close date
- 5
- Expected awards
The verdict
Prescription Drug Overdose: Boost for State Prevention is a closed discretionary listing from Centers for Disease Control and Prevention that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.
- Varies
- award range
- Closed
- application status
- 5
- expected awards
- 93.136
- CFDA program
Archived opportunity record
Prescription Drug Overdose: Boost for State P… is closed (last close June 4, 2014). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 4, 2014
Est. Total Funding
$6,000,000
Expected Awards
5
Instrument
Cooperative Agreement
Description
The purpose of this funding is to advance and evaluate comprehensive state-level interventions for preventing prescription drug misuse, abuse, and overdose. Interventions of interest address patient and prescriber behaviors that drive the prescription drug overdose epidemic, particularly the misuse and inappropriate prescribing of opioid pain relievers. Specifically, awardees will perform activities that support at least two of the following complementary key prevention strategies to prevent prescription drug misuse, diversion, and overdose: enhancing and maximizing prescription drug monitoring programs (PDMPs); improving and evaluating state health insurance mechanisms to prevent prescription drug misuse, diversion, and overdose (e.g., via Medicaid or workers’ compensation); and evaluating state-level laws, policies, and regulations (e.g., legislation regulating pain clinics, or supporting clinical practice guidelines). The primary outcomes of interest may vary by strategy. They might include programmatic outcomes (e.g., mandatory PDMP registration and use, enrollment in patient review and restriction programs), behavior change (e.g., decrease prescribing inconsistent with clinical guidelines, decreased doctor shopping), and/or health-related outcomes (e.g., decrease in emergency department visits due to misuse or abuse of controlled prescription drugs, decreased drug overdose death rate). State-level engagement is critical to the success of this FOA given the concentration of the authority to address the use and misuse of prescription drugs within state government. Multi-sector collaboration with partners that have shared authority over this issue is also needed (e.g., law enforcement, boards of pharmacy, medical boards, mental health and substance abuse services, medical centers, lead state agencies for Medicaid programs.) Applicants are therefore required to submit letters of support from state-level governmental entities and other partners depending on the strategies they pursue under their work plan.
Catch-all / unrestricted eligibility mark · CDC-RFA-CE14-1404
Grants.gov marks Prescription Drug Overdose: Boost for State P… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700
More from Centers for Disease Control and Prevention
What to do next
Prescription Drug Overdose: Boost for State P… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.136 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |